During the past decade, LLC Vivamedi conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 3 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "LLC Vivamedi" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "LLC Vivamedi" are "Ulcerative Colitis" (5 trials), "Crohn Disease" (3 trials) and "Crohn's Disease" (1 trials). Many other conditions were trialed in "LLC Vivamedi" in a lesser frequency.

Most popular intervention types in "LLC Vivamedi" are "Drug" (9 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Etrasimod" (4 trials), "Ozanimod" (3 trials) and "RPC1063" (2 trials). Other intervention names were less common.

The vast majority of trials in "LLC Vivamedi" are 9 trials for "All" genders.

Currently, there are NaN active trials in "LLC Vivamedi". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in LLC Vivamedi, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in LLC Vivamedi, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".